HealthCare Journey for Multiple Sclerosis
  • Home
  • About Us
  • News & Resources
  • Virtual MS Center
    • Q & A for Virtual MS Center
    • Read About Our Virtual MS Center Staff
  • Health & Wellness
  • Blogs
    • Physician Blog >
      • Healthcare Provider Blog
    • Physical Therapy Blog
    • Patient Blog
    • Caregiver Blog
    • Research Blogs >
      • "Ask Dr. Debbie" Research Blog
      • Multiple Perspectives In Multiple Sclerosis Research Blog
  • About MS
    • What is MS?
    • Diagnosis
    • Treatment
    • MS Tips
  • Symptoms
    • Balance and Walking Issues
    • Breathing/Respiratory
    • Bowel Dysfunction
    • Cognitive Dysfunction
    • Crying/Laughing Uncontrollably (PBA)
    • Depression and Anxiety
    • Dizziness/Vertigo
    • Dysphagia
    • Fatigue
    • Foot Drop
    • Hearing or Smell or Taste Changes
    • Heat Sensitivity
    • Leg Weakness
    • Loss of Hand Dexterity and Coordination
    • Memory and Mutliple Sclerosis
    • Migraines
    • Numbness/Tingling/Altered Sensation
    • Nystagmus and Oscillopsia
    • Pain
    • Sexual Dysfunction
    • Sleep Issues
    • Spasticity/Spasms/Cramps
    • Speech/Swallowing
    • Urination/Bowel Problems
    • Vision
  • MS Clinics
  • MS Topics
    • Pregnancy and Infertility
    • Caregivers and Family Members
    • Employment and MS
    • Medical Costs and Insurance
    • Pediatric Multiple Sclerosis
  • Register With Us
  • Terms of Use/Privacy/HIPAA
  • Store Your Images
  • MS HealthCare Journey
  • expo
  • Resiliency

Welcome to the
Virtual MS Center!


You can ask any question you want about Multiple Sclerosis and one of our experts will answer it.  Click below to ask your question and the answer will be posted to this page as soon as possible.

CLICK HERE TO ASK YOUR QUESTION!

What is the benefit of a 6 or 8 week dosing regimen for Tysabri?

1/22/2015

3 Comments

 
Here is My Question:
After 2 years on Tysabri my neurologist suggested that I start getting infusions each 6 weeks instead of each 4 weeks, even though I am JCV negative. What would be the benefit? What is the evidence about efficacy of 6 week or 8 week dosing regimen? Thanks!


Answer:

Good question.

The main reason such a change in dosing frequency (from every 4 weeks to every 6 or 8 weeks) is considered is based on preliminary evidence that doing so may reduce the risk of progressive multifocal leukoencephalopthy (PML) while maintaining the effectiveness of Tysabri.

The rationale behind this is that we know that Tysabri saturates alpha-4-beta-1 integrin receptor by >80% after the infusion, and the saturation remains above 75% when you go back to get your next infusion 4 weeks later.  At 6-8 weeks after the infusion, the saturation drops to ~70% and then ~40% two weeks later.  The interaction between this receptor on your white blood cells and the blood vessel wall allows the cell to get into the central nervous system and potentially lead to an MS relapse.  Tysabri blocks this interaction which is presumably why it works so well in reducing the number of clinical attacks, MRI lesions, and attenuating disability over time.

This receptor-Tysabri interaction is a double-edged sword, however.  The white blood cells are also needed to survey the central nervous system and eradicate foreign invaders (ie, the JC-virus that causes PML).  So, by altering the dosing frequency of tysabri, we are hoping to allow enough saturation of the integrin receptor by tysabri to protect patients from MS but at the same time, allow enough opportunity for the white blood cells to gain access to the nervous system to "keep an eye" on foreign viruses--particularly the one that causes PML.

Preliminary data on this topic presented at the American Academy of Neurology meeting in 2014 can be found below:
Mitigating PML While Maintaining Efficacy
File Size: 1021 kb
File Type: pdf
Download File

This multicenter observational data is preliminary but so far suggests that extending the dosing of Tysabri to every 6 to 8 weeks appears to maintain the drug's effectiveness against MS and at the same time, they have not observed a case of PML.  Of course, this is just preliminary, and they are continuing the observational study to confirm these findings.

Hope this helps.

A. Scott Nielsen MD MMSc
Virginia Mason Multiple Sclerosis Clinic
3 Comments

    RSS Feed

    PLEASE NOTE:  The information/opinions on this site should be used as an information resource only.  This information does not create any patient-HCP relationship, and should not be used as a substitute for professional diagnosis and treatment.  Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition.
    Read About Our Virtual MS Center Authors

    Archives

    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    July 2013
    June 2013

    Categories

    All
    Accessible Housing And Environmental Modifications
    Anxiety
    Balance
    Bowel Problems
    Caregivers
    Cognitive Function
    Compliance
    David Rintell Ed. D.
    Deborah Backus Blogs
    Depression
    Diagnosis
    Diet
    Dizziness
    Dosing
    Dr. Greenberg's Q&A
    Dr. Kinkel's Q&A
    Dr. Miravalle's Q&A
    Dr. Nielsen's Q&A
    Dr. Osborne's Q&A
    Exercise
    Experimental Treatments
    Eye Surgery
    Fatigue
    Fatique
    Flu Shot
    Foot Drop
    Herbs
    Immunosuppression
    JCV
    Lasik Surgery
    Lesions
    Lori Kostich's Q&A
    Lyme Disease
    Medications
    Migraines
    Mobility
    MRI
    MS Hug
    Other Diseases
    Pain
    PML
    PPMS
    Pregnancy
    Relapse
    Safety
    Sarah Wargo's Q&A
    Sexual Dysfunction
    Side Effects
    Smoking
    Spasticity
    Stem Cell Transplantation
    Steroids
    Stress
    Supplements
    Surgery
    Symptoms
    Treatment
    Urination
    Viruses
    Vision
    Vitamin D
    Vitamins
    Weakness


© 2018 HealthCare Journey, LLC. All Rights Reserved.
HealthCare Journey™ is a trademark of HealthCare Journey, LLC
Picture
✕